• Something wrong with this record ?

GWAS-Identified Variants for Obesity Do Not Influence the Risk of Developing Multiple Myeloma: A Population-Based Study and Meta-Analysis

JM. Sánchez-Maldonado, AJ. Cabrera-Serrano, S. Chattopadhyay, D. Campa, MDP. Garrido, A. Macauda, R. Ter Horst, A. Jerez, MG. Netea, Y. Li, K. Hemminki, F. Canzian, A. Försti, J. Sainz

. 2023 ; 24 (7) : . [pub] 20230323

Language English Country Switzerland

Document type Meta-Analysis, Journal Article

Persistent link   https://www.medvik.cz/link/bmc23010640

Grant support
PI17/02256 Instituto de Salud Carlos III
PI20/01845 Instituto de Salud Carlos III
BMBF: CLIOMMICS [01ZX1309] German Ministry of Education and Science
PY20/01282 PAIDI, Consejería de Salud y Familia de la Junta de Andalucía, Spain

Multiple myeloma (MM) is an incurable disease characterized by the presence of malignant plasma cells in the bone marrow that secrete specific monoclonal immunoglobulins into the blood. Obesity has been associated with the risk of developing solid and hematological cancers, but its role as a risk factor for MM needs to be further explored. Here, we evaluated whether 32 genome-wide association study (GWAS)-identified variants for obesity were associated with the risk of MM in 4189 German subjects from the German Multiple Myeloma Group (GMMG) cohort (2121 MM cases and 2068 controls) and 1293 Spanish subjects (206 MM cases and 1087 controls). Results were then validated through meta-analysis with data from the UKBiobank (554 MM cases and 402,714 controls) and FinnGen cohorts (914 MM cases and 248,695 controls). Finally, we evaluated the correlation of these single nucleotide polymorphisms (SNPs) with cQTL data, serum inflammatory proteins, steroid hormones, and absolute numbers of blood-derived cell populations (n = 520). The meta-analysis of the four European cohorts showed no effect of obesity-related variants on the risk of developing MM. We only found a very modest association of the POC5rs2112347G and ADCY3rs11676272G alleles with MM risk that did not remain significant after correction for multiple testing (per-allele OR = 1.08, p = 0.0083 and per-allele OR = 1.06, p = 0.046). No correlation between these SNPs and functional data was found, which confirms that obesity-related variants do not influence MM risk.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23010640
003      
CZ-PrNML
005      
20230801132545.0
007      
ta
008      
230718s2023 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/ijms24076029 $2 doi
035    __
$a (PubMed)37047000
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Sánchez-Maldonado, José Manuel $u Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, PTS, 18016 Granada, Spain $1 https://orcid.org/0000000246513675
245    10
$a GWAS-Identified Variants for Obesity Do Not Influence the Risk of Developing Multiple Myeloma: A Population-Based Study and Meta-Analysis / $c JM. Sánchez-Maldonado, AJ. Cabrera-Serrano, S. Chattopadhyay, D. Campa, MDP. Garrido, A. Macauda, R. Ter Horst, A. Jerez, MG. Netea, Y. Li, K. Hemminki, F. Canzian, A. Försti, J. Sainz
520    9_
$a Multiple myeloma (MM) is an incurable disease characterized by the presence of malignant plasma cells in the bone marrow that secrete specific monoclonal immunoglobulins into the blood. Obesity has been associated with the risk of developing solid and hematological cancers, but its role as a risk factor for MM needs to be further explored. Here, we evaluated whether 32 genome-wide association study (GWAS)-identified variants for obesity were associated with the risk of MM in 4189 German subjects from the German Multiple Myeloma Group (GMMG) cohort (2121 MM cases and 2068 controls) and 1293 Spanish subjects (206 MM cases and 1087 controls). Results were then validated through meta-analysis with data from the UKBiobank (554 MM cases and 402,714 controls) and FinnGen cohorts (914 MM cases and 248,695 controls). Finally, we evaluated the correlation of these single nucleotide polymorphisms (SNPs) with cQTL data, serum inflammatory proteins, steroid hormones, and absolute numbers of blood-derived cell populations (n = 520). The meta-analysis of the four European cohorts showed no effect of obesity-related variants on the risk of developing MM. We only found a very modest association of the POC5rs2112347G and ADCY3rs11676272G alleles with MM risk that did not remain significant after correction for multiple testing (per-allele OR = 1.08, p = 0.0083 and per-allele OR = 1.06, p = 0.046). No correlation between these SNPs and functional data was found, which confirms that obesity-related variants do not influence MM risk.
650    _2
$a lidé $7 D006801
650    12
$a celogenomová asociační studie $x metody $7 D055106
650    _2
$a genetická predispozice k nemoci $7 D020022
650    12
$a mnohočetný myelom $x genetika $7 D009101
650    _2
$a rizikové faktory $7 D012307
650    _2
$a obezita $x komplikace $x genetika $7 D009765
650    _2
$a jednonukleotidový polymorfismus $7 D020641
650    _2
$a transportní proteiny $7 D002352
655    _2
$a metaanalýza $7 D017418
655    _2
$a časopisecké články $7 D016428
700    1_
$a Cabrera-Serrano, Antonio José $u Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, PTS, 18016 Granada, Spain $1 https://orcid.org/0000000303467960
700    1_
$a Chattopadhyay, Subhayan $u Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany $u Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), 69120 Heidelberg, Germany $u Hopp Children's Cancer Center (KiTZ), 69120 Heidelberg, Germany
700    1_
$a Campa, Daniele $u Department of Biology, University of Pisa, 56126 Pisa, Italy
700    1_
$a Garrido, María Del Pilar $u Hematology Department, Virgen de las Nieves University Hospital, 18012 Granada, Spain
700    1_
$a Macauda, Angelica $u Genomic Epidemiology Group, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany
700    1_
$a Ter Horst, Rob $u Department of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Nijmegen Medical Center, 6525 GA Nijmegen, The Netherlands
700    1_
$a Jerez, Andrés $u Department of Hematology, Experimental Hematology Unit, Vall d'Hebron Institute of Oncology (VHIO), University Hospital Vall d'Hebron, 08035 Barcelona, Spain $1 https://orcid.org/0000000220796638
700    1_
$a Netea, Mihai G $u Department of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Nijmegen Medical Center, 6525 GA Nijmegen, The Netherlands $u Department for Immunology & Metabolism, Life and Medical Sciences Institute (LIMES), University of Bonn, 53115 Bonn, Germany
700    1_
$a Li, Yang $u Department of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Nijmegen Medical Center, 6525 GA Nijmegen, The Netherlands $u Centre for Individualised Infection Medicine (CiiM) & TWINCORE, Joint Ventures between the Helmholtz-Centre for Infection Research (HZI) and the Hannover Medical School (MHH), 30625 Hannover, Germany $1 https://orcid.org/0000000340227341
700    1_
$a Hemminki, Kari $u Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany $u Germany Division of Cancer Epidemiology, German Cancer Research Centre (DKFZ), 69120 Heidelberg, Germany $u Faculty of Medicine and Biomedical Center in Pilsen, Charles University in Prague, 30605 Pilsen, Czech Republic $1 https://orcid.org/0000000227693316 $7 mzk20201092711
700    1_
$a Canzian, Federico $u Genomic Epidemiology Group, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany $1 https://orcid.org/0000000242614583
700    1_
$a Försti, Asta $u Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), 69120 Heidelberg, Germany $u Hopp Children's Cancer Center (KiTZ), 69120 Heidelberg, Germany $1 https://orcid.org/0000000298574728
700    1_
$a Sainz, Juan $u Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, PTS, 18016 Granada, Spain $u Department of Biochemistry and Molecular Biology I, University of Granada, 18071 Granada, Spain $1 https://orcid.org/0000000293552423
773    0_
$w MED00176142 $t International journal of molecular sciences $x 1422-0067 $g Roč. 24, č. 7 (2023)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37047000 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230718 $b ABA008
991    __
$a 20230801132542 $b ABA008
999    __
$a ok $b bmc $g 1963219 $s 1196905
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 24 $c 7 $e 20230323 $i 1422-0067 $m International journal of molecular sciences $n Int J Mol Sci $x MED00176142
GRA    __
$a PI17/02256 $p Instituto de Salud Carlos III
GRA    __
$a PI20/01845 $p Instituto de Salud Carlos III
GRA    __
$a BMBF: CLIOMMICS [01ZX1309] $p German Ministry of Education and Science
GRA    __
$a PY20/01282 $p PAIDI, Consejería de Salud y Familia de la Junta de Andalucía, Spain
LZP    __
$a Pubmed-20230718

Find record

Citation metrics

Archiving options